HUSSMAN STRATEGIC ADVISORS, INC. - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 3 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
HUSSMAN STRATEGIC ADVISORS, INC. ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,194,120
-9.5%
124,0000.0%0.23%
-6.2%
Q2 2023$1,319,360
-19.6%
124,000
-20.5%
0.24%
-5.4%
Q1 2023$1,641,120
-15.1%
156,0000.0%0.26%
-18.4%
Q4 2022$1,932,840
+19.6%
156,0000.0%0.32%
+12.9%
Q3 2022$1,616,000
-10.2%
156,0000.0%0.28%
-10.0%
Q2 2022$1,799,000
+175.1%
156,000
+200.0%
0.31%
+144.1%
Q1 2022$654,000
-28.1%
52,000
-33.3%
0.13%
-36.2%
Q4 2021$909,00078,0000.20%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
HealthInvest Partners AB 1,520,000$19,562,00018.54%
Sarissa Capital Management LP 16,390,000$210,939,00016.77%
Healthcare Value Capital, LLC 200,000$2,574,0005.13%
Camber Capital Management LP 7,500,000$96,525,0003.25%
13D Management LLC 650,455$8,371,0002.88%
BRIDGER MANAGEMENT, LLC 2,035,114$26,192,0002.44%
Brown Capital Management 18,484,759$237,899,0001.80%
Healthcare Value Capital, LLC 50,000$644,0001.28%
Zebra Capital Management LLC 53,359$687,0000.80%
PRICE MICHAEL F 520,000$6,692,0000.74%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders